Benzoyleneurea
Benzoyleneurea possesses anti-bacterial activity. Benzoyleneurea scaffold can be used in the synthesis of novel protein geranylgeranyltransferase-I (PGGTase-I) inhibitors[1].
Product Specifications
CAS Number
86-96-4
Product Name Alternative
Quinazolinedione
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/benzoyleneurea.html
Purity
99.67
Solubility
DMSO : 43.33 mg/mL (ultrasonic) |H2O : < 0.1 mg/mL
Smiles
O=C(N1)NC2=C(C=CC=C2)C1=O
Molecular Formula
C8H6N2O2
Molecular Weight
162.15
Precautions
H302, H315, H319, H335
References & Citations
[1]Carrico D, et al. Design, synthesis, and evaluation of potent and selective benzoyleneurea-based inhibitors of protein geranylgeranyltransferase-I. Bioorg Med Chem. 2005 Feb 1;13 (3) :677-88.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
